Correction: Reproducing the normal and the pathological in personalized cancer medicine clinical trials(BioSocieties, 10.1057/s41292-024-00329-y)

Nadav Even Chorev, Dani Filc

Research output: Contribution to journalComment/debate

Abstract

The Acknowledgements section was missing from this article and should have read ‘We wish to thank the editors of BioSocieties for their guidance, and the three anonymous reviewers for their insightful comments. We also thank Prof. David S. Jones of the Department of the History of Science at Harvard University for comments on previous versions of the text. The text also benefited from comments by Dr. Mauro Turini, Institute of Public Goods and Policies (IPP), Spanish National Research Council (CSIC), Madrid, Spain; the participants of the History of Medicine Working Group at the Department of the History of Science at Harvard University, 2020; and the participants at the STS Italia conference session on “Dis/entangling living bodies and medical technologies in the post-genomic era”, June 2021’.

Original languageEnglish
JournalBioSocieties
DOIs
StateAccepted/In press - 1 Jan 2024

ASJC Scopus subject areas

  • Health(social science)
  • Health Policy

Fingerprint

Dive into the research topics of 'Correction: Reproducing the normal and the pathological in personalized cancer medicine clinical trials(BioSocieties, 10.1057/s41292-024-00329-y)'. Together they form a unique fingerprint.

Cite this